Postsynaptic density 95 (PSD-95), the major scaffold at excitatory synapses, is critical for synapse maturation and learning. In rodents, eye opening, the onset of pattern vision, triggers a rapid movement of PSD-95 from visual neuron somata to synapses. We showed previously that the PI3 kinase-Akt pathway downstream of BDNF/TrkB signaling stimulates synaptic delivery of PSD-95 via vesicular transport. However, vesicular transport requires PSD-95 palmitoylation to attach it to a lipid membrane. Also, PSD-95 insertion at synapses is known to require this lipid modification. Here, we show that BDNF/TrkB signaling is also necessary for PSD-95 palmitoylation and its transport to synapses in mouse visual cortical layer 2/3 neurons. However, palmitoylation of PSD-95 requires the activation of another pathway downstream of BDNF/TrkB, namely, signaling through phospholipase C␥ and the brain-specific PKC variant protein kinase M (PKM). We find that PKM selectively regulates phosphorylation of the palmitoylation enzyme ZDHHC8. Inhibition of PKM results in a reduction of synaptic PSD-95 accumulation in vivo, which can be rescued by overexpressing ZDHHC8. Therefore, TrkB and PKM, two critical regulators of synaptic plasticity, facilitate PSD-95 targeting to synapses. These results also indicate that palmitoylation can be regulated by a trophic factor. Our findings have implications for neurodevelopmental disorders as well as aging brains.
Introduction
Postsynaptic density 95 (PSD-95) is the major PSD scaffolding protein for ionotropic glutamate receptors and the signaling molecules through which these receptors function (Kim and Sheng, 2004) . Overexpression of PSD-95 increases spine number, size, and synaptic efficacy (El-Husseini et al., 2000a) . In the visual pathway of rodents, rapid increases in synaptic PSD-95 precede increases in synaptic strength and refinement that occur during the period encompassing eye opening (EO) (Yoshii et al., 2003; Lu and Constantine-Paton, 2004) . Hippocampal slices lacking PSD-95 show prolonged NMDA receptor (NMDAR) mediated Ca 2ϩ currents (Beique et al., 2006) and, in cultured slices, a reduced developmental increase of AMPA receptors (AMPARs) (Ehrlich et al., 2007) . PSD-95 knock-out mice show disrupted spatial learning and no long-term depression (LTD) but have enhanced long-term potentiation (LTP) (Migaud et al., 1998) . Conversely, overexpression of PSD-95 occludes LTP while enhancing LTD (Beique and Andrade, 2003; Stein et al., 2003; Ehrlich and Malinow, 2004) . These findings suggest that PSD-95 levels are critical for activity-dependent regulation of NMDARs and AMPARs by setting the range of upregulation or downregulation of these receptors.
BDNF and its receptor TrkB participate in many aspects of neural circuit formation (McAllister et al., 1999; Poo, 2001; Huang and Reichardt, 2003; Minichiello, 2009; Yoshii and Constantine-Paton, 2010) . In the central visual pathway, EO and the onset of pattern vision increase BDNF/TrkB signaling (Castren et al., 1992; Viegi et al., 2002) , the formation of mature dendritic spines (Chakravarthy et al., 2006) , and visual cortical plasticity (Cabelli et al., 1995) . BDNF also facilitates the maturation of inhibition implicated in closure of the critical period for ocular dominance plasticity (Huang et al., 1999) . TrkB colocalizes with NMDA receptors (Gomes et al., 2006) , and interacts with PSD-95 in an activity-dependent manner (Ji et al., 2005; Yoshii and Constantine-Paton, 2007) . Furthermore, both BDNF/ TrkB signaling and a brain-specific protein kinase C variant, protein kinase M (PKM), are involved in late-LTP (Kang and Schuman, 1995; Korte et al., 1995; Figurov et al., 1996; Patterson et al., 1996; Poo, 2001; Kovalchuk et al., 2002; Pastalkova et al., 2006; Minichiello, 2009) , and maintenance of long-term memory (Alonso et al., 2005; Pastalkova et al., 2006; Shema et al., 2007) . BDNF increases the expression and activity of PKM (Adasme et al., 2011) .
We showed previously that BDNF/TrkB signaling through the PI3 kinase-Akt pathway facilitates PSD-95 transport to synapses via vesicular transport (Ji et al., 2005; Yoshii and Constantine-Paton, 2007) . Here, we employ a genetically modified mouse strain, TrkB F616A , to specifically block the receptor and show that TrkB activation is also necessary for trafficking PSD-95 to visual synapses after eye opening (AEO) in vivo. We also report that BDNF/TrkB signaling regulates palmitoylation of PSD-95. To our surprise, this process is mediated by PLC and PKM. Inhibition of PKM also suppresses the synaptic redistribution of PSD-95 in visual cortical layer 2/3 pyramidal neurons. Furthermore, the phosphorylation of palmitoyl acyltransferase (PAT) ZDHHC8 is regulated by PKM. Finally, we demonstrate that ZDHHC8 overexpression rescues the suppression of synaptic transport of PSD-95 by a PKM blocking peptide in vivo.
Materials and Methods

Animals. TrkB
F616A mice were kindly provided by Dr. David Ginty (Johns Hopkins University, Baltimore, MD). Wild-type (WT) C57BL6, mice were from Charles River Laboratories. Animals were caged and maintained in a 12 h light/dark cycle. Both sexes were used for experiments. All manipulations were performed in accord with the guidelines of the Massachusetts Institute of Technology (MIT) Institutional Animal Care and Use Committee.
Chemicals. 1-(Tert-butyl)-3-(naphthalen-1-ylmethyl)-1H-pyrazolo [3,4-d] pyrimidin-4-amine (1NM-PP1) and 3-([1,1Ј-biphenyl]-4-yl)-1-(tert-butyl)-1H-pyrazolo [3,4-d] pyrimidin-4-amine (BPh-PP1) were prepared using procedures described previously (Bishop et al., 1999) . Their chemical structures are shown in Figure 1 A. These were applied chronically using the slow release plastic Elvax. U73122 (PLC inhibitor), chelerythrine, PD98059 (mitogen-activated protein kinase inhibitor), and wortmannin were purchased from Sigma-Aldrich. The PKM inhibitory pseudosubstrate (myr-SIYRRGARRWRKL-OH) and scrambled peptide (myr-RLYRKRIWRSAGROH) (Pastalkova et al., 2006) were made in the MIT Biopolymers Laboratory.
Elvax preparation. Elvax was made as described previously (Simon et al., 1992) . 1NM-PP1 or Bph-PP1 (25 mM) was prepared in a 10% Elvax solution in methylene chloride. The solvent was evaporated at 20°C, and the resulting plugs were lyophilized overnight, then sliced at 90 m on a cryostat. Slices were cut to trapezoid-shape (parallel sides, 2-3 ϫ 4 -5 mm; height, 4 -5 mm). Following craniotomy under isoflurane anesthesia, pieces of Elvax were placed on the surface of both occipital cortices.
TUNEL assay. The FragEL DNA Fragmentaion Detection Kit (Calbiochem) was used for the TUNEL assay. The procedures were performed according to the manufacturer's instructions.
Antibodies. For immunoblotting, mouse monoclonal anti-PSD-95 (catalog #K28/43; NeuroMab), anti-TrkB antibody (catalog #T16020; BD Biosciences), anti-phospho-TrkB (catalog #ab51187; Abcam), anti-SAP102 (synapse-associated protein 102, kindly provided by Dr. Johannes Hell, UC Davis, Davis, CA), anti-HA tag (catalog #3724; Cell Signaling Technology), and anti-phospho-(Ser) PKC substrate (catalog #2261; Cell Signaling Technology) antibodies were used. For immunohistochemistry, rabbit anti-PSD-95 (catalog #2507; Cell Signaling Technology) was used.
Plasmid construction. The 2A cleavage sequence from Thosea asigna virus together with the nucleotide sequences encoding PKM pseudosubstrate or its scrambled peptide were attached by PCR to the TagRFP-T sequence using the following primers (Szymczak et al., 2004; Trichas et al., 2008) : universal forward primer, cgatcaattgatggtgtctaagggcgaagagctgattaag; first PCR reverse primer, gttagcagacttcctctgccctctccactgcccttatacagctcgtccatgccattaag; second PCR reverse primer, cttgggccaggattctcctcgacgtcaccgcatgttagcagacttcctctgccctctccac; third PCR reverse primer for pseudo-PKM substrate, gttatgtacatcacagcttcctccacctcctggcgcccctcctgtagatgcttgggccaggattctcctcgacg; reverse primer for scramble peptide, gttatgtacatcacctgccggcgctcctccagatcctcttcctatacagccttgggccaggattctcctcgacg.
The modified TagRFP-T sequences were inserted under the CAG promoter of the pCAGIG plasmid by replacing the IRES and GFP sequences. TagRFP-T was a gift from the laboratory of R. Tsien (UCSD, San Diego CA). pCAGIG was originally from the laboratory of the C. Cepko (Harvard Medical School, Boston, MA).
Synaptosome fractionation, immunoblotting, immunoprecipitation. Identification of visual cortex (VC) was based on the Paxinos atlas (Paxinos and Franklin, 2001) . The VC tissues were collected by cutting the occipital onethird of the cortex along the anteroposterior axis and 3 mm from the midline along mediolateral axis. Whole lysates, synaptosome preparation, and immunoblotting were performed as described previously (Yoshii et al., 2003) . Protein concentration of each sample was measured using the Pierce BCA Protein Assay Kit (Thermo Scientific), and 10 g of sample was loaded in each lane for SDS-PAGE separation. Following immunoblotting, films were scanned and band densities were quantified using NIH ImageJ. Full-length TrkB bands were constant between postnatal day 10 (P10) and P16; thus, phosphorylated TrkB (pTrkB) and PSD-95 band densities were normalized to the TrkB band. Control samples at P16 showed highest levels of PSD-95 and pTrkB; thus, fold changes at each time point were calculated relative to the protein level at P16 control on the same gels ( Fig. 1G-J,L,M) . Results are reported as mean Ϯ SEM.
All immunoblot analyses used three sets of protein samples from three different litters. Two gels were run for each sample and blotted (N ϭ 6).
Primary neuronal culture and lipofection. Primary neuronal culture and lipofection were performed as described previously (Ji et al., 2005; Yoshii and Constantine-Paton, 2007 ).
Metabolic labeling with 3 H palmitic acid and immunoprecipitation. Primary VC cultures were prepared from embryonic day 16 (E16) mouse brains. Cultured visual cortical neurons (6 ϫ 10 6 cells/plate; 21-28 d in vivo) were preincubated for 30 min in serum-free Neurobasal medium with fatty acid-free bovine serum albumin (10 mg/ml; Sigma), and were then labeled for 4 h in neurobasal media containing 2 mCi/ml 3 H palmitic acid (PerkinElmer) with or without BDNF and/or various blockers. Labeled neurons were washed with PBS. BDNF and/or inhibitors were added from the preincubation period through the end of the 4 h incubation period.
To observe PSD-95 palmitoylation, we scraped labeled neurons using 0.5 ml of lysis buffer A (20 mM Tris-HCl, pH 7.4, 1 mM EDTA, 100 mM NaCl, and 1% SDS), and after 5 min extraction, 1% Triton X-100 was added to a final volume of 1 ml. The suspensions were centrifuged at 20,000 ϫ g for 10 min, and supernatants were incubated with anti-PSD-95 antibody for 1 h and then incubated for 1 h with 30 l of protein A-Sepharose (Pharmacia) slurry at 4°C. Immunoprecipitates were washed three times with buffer containing 20 mM Tris-HCl, pH 7.4, 1 mM EDTA, 100 mM NaCl, and 1% Triton X-100, and were resuspended in 33 l of SDS-PAGE sample buffer. We used 30 l for autoradiography and the remaining 3 l for immunoblotting. The ratios of palmitoylated PSD-95 densities in autoradiographies to total PSD-95 densities in corresponding immunoblots were calculated. Each experiment was repeated four times.
Immunohistochemistry. After 4% paraformaldehyde perfusion and vibratome sectioning at 50 m, coronal brain sections were permeabilized using pepsin (Gene Tex; catalog #GTX28194) at 37°C for 10 min and were rinsed twice with PBS. The sections were reacted overnight at room temperature with mouse anti-PSD-95 in PBS containing 4% donkey serum and were rinsed in three changes of PBS (15 min each). Subsequently, they were incubated in Alexa-488-tagged antibody (Invitrogen) and then washed with PBS three times (15 min each). Images were captured using a 40ϫ objective lens under identical settings with a Nikon PCM 2000 confocal microscope. The visual cortex was identified on coronal sections using the Paxinos atlas. The Z-series of optical sections taken at intervals of 0.5 m through 20 m of tissue were reconstructed.
In utero electroporation. Following laparotomy on timed pregnant mice, the uterus was externalized. Approximately 0.5-0.6 l of solution containing PSD-95-GFP construct (2 g/l) was injected into the forebrain ventricle at E15.5 through the uterine wall. In later experiments, constructs encoding red fluorescent protein (RFP)-tagged pseudosubstrate and/or HA-tagged ZDHHC8 were added at 0.01 g/l. Using an ECM 830 apparatus (Harvard Apparatus), brains were electroporated with five pulses of 28 V for 50 ms at intervals of 950 ms. After recovery, pregnancies continued, and pups were delivered and nursed normally.
Cortical injection. The PKM inhibitory pseudosubstrate and scrambled peptide were dissolved in PBS to a concentration of 10 nmol/ml. Under isoflurane anesthesia, the skin was opened. The skull was thinned with a drill. A pulled capillary pipette connected to a Nanoject II (Drummond Scientific) could then be stereotactically advanced to 350 m below the skull surface to target visual cortical layer 2/3. One hundred and eighty nanoliters of a PKM pseudosubstrate peptide solution containing Cholera-toxin B conjugated with Alexa-647 (Invitrogen) were injected over 1 min. In each animal, injections were made in four different sites of the visual cortex. The eyes were opened immediately after the surgery at P13. For each experiment described, data were acquired from three experimental animals and three controls.
Imaging analysis. Sections containing PSD-95-GFP-expressing neurons were imaged at successive depths of 0.5 m using a Nikon PCM 2000 confocal microscope. In each experiment, data were acquired from three experimental animals and three controls. The same laser intensity was used between treatment and control groups, and all analyzed neurons included the cell's nucleus indicated by a "halo" pattern of GFP signal in somata. Neurons with a soma showing fluorescence either saturated (intensity value of 255 throughout the nucleus in ImageJ) or dim (intensity value Ͻ150 in ImageJ) were excluded from the analyses. Total pixel intensities were analyzed with ImageJ. Secondary branches of apical dendrites located between 60 -150 m from the soma were selected with 40 ϫ 20 m rectangles. For each cell analyzed, a threshold was set by eye during the initial evaluation so as to represent PSD-95-GFP puncta and exclude diffuse labels in dendritic shafts (see Fig. 3C ). The same threshold was applied to all neurons in the same experiment. Total pixel intensity The TUNEL assay showed no apoptosis in VC under the 1NM-PP1-Elvax (left) or Bph-PP1-Elvax (middle). As a positive control, slices were treated with DNase (right). Scale bar, 10 m. E, During the period bracketing eye opening, in whole lysates of WT mouse VC, PSD-95 and pTrkB increased, whereas full-length TrkB (FL-TrkB) levels remained constant. F, Both pTrkB and PSD-95 levels were suppressed in whole lysates of VC when TrkB was blocked with 1NM-PP1. FL-TrkB levels in the same lanes are used to normalize because their levels remained constant. G, H, Both pTrkB (G) and PSD-95 (H ) levels were similar between WT and Bph-PP1-treated control VC. I, J, Both pTrkB (I ) and PSD-95 (J ) levels were suppressed in whole lysates of VC when TrkB was blocked with 1NM-PP1. K-M, When TrkB was blocked in VC over the interval encompassing the eye opening (P10 -P16), both phosphorylated TrkB (K, L) and PSD-95 (K, M ) increased normally in the same animals' superficial visual layers of the superior colliculus (sSC), indicating that the blocking effect was restricted to cortex. The blots in C-F and K were first probed for pTrkB, then stripped and probed for PSD-95 and FL-TrkB. *p Ͻ 0.05; **p Ͻ 0.01; ***p Ͻ 0.001. Error bars represent SEM.
was calculated as the sum of each pixel number multiplied by its intensity as measured above threshold for each cell. This value was then averaged across all dendritic segments sampled in the experiment.
Neurolucida software (MBF Bioscience) was used for quantitative analyses of neuronal morphology, including PSD-95 puncta number, branching, and largest cell body area.
Statistics. Student's t tests was used for comparison of two groups. One-way ANOVA with a post hoc Tukey's test was used for comparisons of more than two groups.
Results
Developmental increases in PSD-95 are accelerated by EO and regulated by TrkB
We reported previously that rapid activity-dependent transport of PSD-95 to synapses was triggered by EO in the rat central visual system (Yoshii et al., 2003) , and we have confirmed a similar significant increase in synaptosomal PSD-95 AEO compared to before eye opening (BEO) in WT mouse visual cortex (Fig. 1B ) (PSD-95 AEO /PSD-95 BEO ϭ2.1Ϯ0.2;pϽ0.01;Nϭ6).TrkBphosphorylation was also increased AEO as compared to BEO (pTrkB AEO /pTrkB BEO ϭ 1.8 Ϯ 0.3; p Ͻ 0.01; N ϭ 6).
To test TrkB effects on PSD-95 in visual neurons in vivo, we used a genetically modified mouse strain, TrkB
F616A
, with a mutation in the ATP-binding pocket of TrkB that allows an adenosine analog (1NM-PP1) to specifically block kinase activity of the receptor (Chen et al., 2005) . We surgically implanted thin slices of the slowrelease polymer Elvax containing different concentrations of 1NM-PP1 or a newly developed control compound Bph-PP1 (Fig. 1 A) on the surface of VC at P9. We found a dosedependent decrease in phospho-TrkB (data not shown) and synaptic PSD-95 in 1NM-PP1-treated VC (Fig. 1C) , and subsequently used Elvax with the most effective concentration (25 mM) of 1NM-PP1 or the control molecule Bph-PP1 for all in vivo experiments. No cell death was detected after these implants (Fig. 1 D) .
VC lysate changes in TrkB
F616A mice After normalizing to full-length TrkB in the same lane, both WT mice and TrkB F616A control mice (Bph-PP1-Elvax on VC) showed similar increases in TrkB phosphorylation (Fig. 1 E-G) and in PSD-95 levels ( Fig. 1 E, F,H ) over the EO interval (P12-P14). The different patterns of increase in Figure 1 , G and H, suggest that in VC whole lysates, more TrkB is activated after EO when the cortex becomes driven by high-contrast vision (Heimel et al., 2010) , whereas PSD-95 levels increase from before EO (P12) through at least 3 d afterward.
As expected, ratios of phospho-TrkB to total TrkB in these lysates were significantly reduced in TrkB-suppressed (1NM-PP1-treated) VCs compared to control (Bph-PP1-treated) VCs (Fig.  1 F, I ). Ratios of PSD-95 to total TrkB levels were also suppressed in TrkB-blocked VCs from P12 through P16 (Fig. 1 F, J ) .
In contrast to the VC, PSD-95 levels were not perturbed in the visual layers of the superior colliculus or the dorsal thalamus, indicating that 1NM-PP1 from cortically placed Elvax was not affecting lower levels of the visual pathway ( Fig. 1 K-M ) .
Synaptic analyses in TrkB
F616A mice We found previously in rat that PSD-95 increases in synaptic fractions immediately after EO were not seen in whole lysates and did not require protein synthesis (Yoshii et al., 2003) , suggesting that EO and pattern vision onset acutely trigger trafficking of PSD-95 to the synapse with no new protein synthesis of the scaffold during this interval.
In mouse VC treated with Bph-PP1-Elvax (control), synaptosome PSD-95 levels increased after EO (Fig. 2 A) (synaptosome PSD-95 level change at P14 relative to P12, 1.35 Ϯ 0.05; N ϭ 6). However, 1NM-PP1-Elvax (TrkB blocking) placed on VC suppressed the increase of PSD-95 in the synaptosome compared to the Bph-PP1 after EO (synaptosome PSD-95 level change at P14 relative to P12, 1.01 Ϯ 0.05; N ϭ 6; control vs 1NM-PP1, p Ͻ 0.05). While synaptosome PSD-95 in control was enriched compared to levels in control whole lysates (Fig. 2 A) , TrkB-blockade with 1NM-PP1-Elvax also suppressed the PSD-95 synaptosome enrichment over whole lysates during the same 2 d interval (Fig.  2 A) (synaptosome enrichment for PSD-95 level in synpatosome/ PSD-95 level in whole lysate: 1.78 Ϯ 0.06 in control, 1.15 Ϯ 0.05 in TrkB block ; p Ͻ 0.01; N ϭ 6).
We previously documented BDNF/TrkB-driven PSD-95 transport in dendrites of cultured neurons from mouse VC (Yoshii and Constantine-Paton, 2007) . As a first step in determining whether TrkB-mediated transport from somata and proximal dendrites to synapses occurred in mouse cortical neurons in vivo, we used immunocytochemistry to examine changes in endoge- nous PSD-95 (Fig. 2 B) . Mice with control Bph-Elvax on one VC and 1NM-PP1 Elvax on the other were maintained over the EO interval, and, after animals were killed and tissue and slices were processed, the local distribution of endogenous PSD-95 was examined in VC layer 2/3 neurons of both cortices. Suppression of TrkB signaling caused a marked reduction in the number and intensity of PSD-95 puncta among the dendrites of these neurons, and layer 2/3 cell bodies were filled by diffuse anti-PSD-95 immunoreactivity. Pixel intensities of PSD-95-positive immunolabels in 20 ϫ 20 m areas (Fig. 2B , dashed square) were sampled and quantified (50,100 Ϯ 1700 A.U.; N ϭ 20). Control neurons in the other VCs of the same mice showed the converse distribution: high densities of PSD-95 throughout the superficial dendrites with PSD-95 immunoreactivity barely visible in layer 2/3 cell bodies (83,900 Ϯ 3600 A.U.; N ϭ 20; p Ͻ 0.001).
To quantify TrkB effects on the distribution of PSD-95 in single neurons, PSD-95-GFP constructs were electroporated into newly generated 2/3 VC neurons of TrkB F616A mice at embryonic day 15.5. At either P9 or P11, 1NM-PP1-Elvax or Bph-PP1-Elvax was placed on their VCs. All animals survived 3 d of Bph-PP1 or 1NM-PP1 treatment. Pups implanted at P9 were killed for cortical analyses at P12 before EO. Eyes of pups implanted on P11 were opened on P13, and pups were killed on P14. We analyzed PSD-95-GFP puncta in littermates after EO (P14) and before EO (P12).
At P14 (after P11 Elvax implantations), PSD-95-GFP-expressing control neurons had many protrusions supporting PSD-95 puncta, whereas neurons treated with 1NM-PP1 had fewer PSD-95 puncta (Fig.  3A) . This difference in numbers of PSD-95-positive protrusions was much more significant for apical dendrite puncta (Fig.  3B ) than basal dendrite puncta (data not shown; p Ͻ 0.05 in only 2 of 13 segments; N ϭ 17 neurons).
Consequently, we focused on apical dendrites and estimated the density of PSD-95-GFP in synaptic puncta by selecting fixed lengths of dendrite at the point of secondary branching (Fig. 3A, boxed areas) and thresholding the images (Fig.  3C ) to best represent synaptic PSD-95-GFP. All pixel intensities in the thresholded segments from each neuron in the control and TrkB-blocked treatment groups were summed separately to give the total pixel intensity for each group (Yoshii and Constantine-Paton, 2007) . The pooled pixel intensity in apical dendrites with TrkB blocked (8540 Ϯ 900 A.U.) was highly significantly reduced relative to the apical dendrite pixel intensities (30,100 Ϯ 3900 A.U.) in control neurons (N ϭ 34 for each group; p Ͻ 0.001).
A Sholl analysis examining differences in numbers of PSD-95 puncta at different distances from somata between Bph-PP1 and 1NM-PP1 treatments of apical dendrite anatomical puncta is shown in Figure 3B and shows significant differences across the apical dendritic tree (N ϭ 17 neurons). Total PSD-95-GFP pixel intensities across 34 basal dendrites of these same neurons were also reduced in 1NM-PP1-compared to Bph-PP1-treated cells; however, the significance was less robust (24,700 Ϯ 5900 A.U. in control vs 6500 Ϯ 1000 A.U. in 1NM-PP1; p Ͻ 0.05). Thus, an effect of TrkB blockade on dendritic protrusions is consistent with the previous report using a dominant-negative TrkB mutant mouse (Chakravarthy et al., 2006) .
In the Sholl analysis, the total dendritic branching was marginally different between TrkB-blocked neurons and controls (p Ͻ 0.05 in only 1 of 15 segments at 70 m from the somata; N ϭ 17). Cell body sizes were also only modestly altered (165 Ϯ 15 m 2 in control vs 140 Ϯ 5 m 2 in 1NM-PP1; p Ͻ 0.05; N ϭ 17). These findings are in contrast with data from Figure 3 . TrkB blockade suppresses increases of PSD-95 synaptic puncta after eye opening. A, PSD-95-GFP-expressing neurons in layer 2/3 of VC were treated in vivo with 1NM-PP1 (TrkB block) or Bph-PP1 (control) over the eye-opening interval. Dashed rectangles are magnified in C. B, Using a Sholl analysis, numbers of PSD-95 puncta on apical dendrites were significantly reduced at many distances from the soma TrkB-blocked neurons after eye opening. The same analysis for basal dendrites showed the same trend, but only 2 Sholl intervals of 13 showed significance at p Ͻ 0.05. C, PSD-95-GFP puncta intensity in secondary branches of apical dendrites was reduced in TrkB-blocked neurons. Three-dimensional graphs show intensities of puncta after thresholding thateliminateGFPsignalindendriticshaftsandallowvisualizationofthePSD-95distributionandintensityalongthedendriticsegment.D, E, Before EO, treatment with Bph-PP1 or 1NM-PP1 from P9 to P12 revealed that PSD-95-GFP puncta intensities in secondary branches of apicaldendriteswereunchangedbetweenneuronstreatedforthesamedurationbutnotovertheeye-openinginterval.Dashedrectangles are magnified in E. *p Ͻ 0.05; **p Ͻ 0.01; ***p Ͻ 0.001. Error bars represent SEM. Scale bars: 10 m.
forebrain-specific TrkB knock-out mice (Xu et al., 2000) . The short-duration block of TrkB in our experiments compared to prolonged absence of the receptor in the knock-out mice could explain these differences.
To determine whether the effect on apical puncta change was due to EO and not simply due to the presence of Elvax on cortex, we performed a similar experiment on the layer 2/3 VC neurons that had also been exposed to 1NM-PP1 for the same duration but not over the EO interval. Before EO, similar low-density distributions of PSD-95-GFP puncta were present in both 1NM-PP1-and Bph-PP1-treated neurons (Fig. 3 D, E) . Total pixel intensities at P12 were 6980 Ϯ 750 A.U. in control VC neurons treated with Bph-PP1 (N ϭ 20) and 6850 Ϯ 1050 A.U. in VC neurons treated with 1NM-PP1 (N ϭ 20; p ϭ 0.33).
TrkB-PLC␥-PKM regulates PSD-95 palmitoylation
Palmitoylation of PSD-95 can be triggered by glutamate (ElHusseini Ael et al., 2002) and is crucial for this scaffold's trafficking and insertion at postsynaptic sites (El-Husseini et al., 2000b) . Our previous work suggested that in young cortical neurons, NMDA receptor currents activate BDNF/TrkB signaling and drive movement of PSD-95 from the ER to the Golgi apparatus in cell bodies before dendritic transport (Yoshii and Constantine-Paton, 2007). However, PSD-95 is synthesized by cytoplasmic ribosomes, implying that it must be palmitoylated to allow association with ER and Golgi membranes. Therefore, we hypothesized that BDNF/TrkB signaling might also trigger palmitoylation, and this might be a trigger for PSD-95 palmitoylation to enable the scaffold's membrane association and microtubule-based vesicular transport to synapses. Despite recent progress in purification of palmitoylation using chemical probing, metabolic labeling with a radioisotope is the standard procedure for identification of palmitoylated proteins (Fukata and Fukata, 2010 ), but radioactive labeling of whole mouse pups was not feasible. Therefore, we dissociated cortical neurons from TrkB F616A mouse embryos and labeled them with 3 H-palmitic acid. Subsequently, we immunopreciptated PSD-95 from lysates of cultures with no treatment or with either BDNF or 1NM-PP1 added. Palmitoylation of PSD-95 from cultures treated with BDNF was higher than without treatment (palmitoylated PSD-95 ratio relative to control, 1.25 Ϯ 0.05: p Ͻ 0.01: N ϭ 4), and palmitoylation of PSD-95 from cultures treated with 1NM-PP1 was the lowest (palmitoylated PSD-95 ratio relative to control, 0.45 Ϯ 0.11; p Ͻ 0.001; N ϭ 4) (Fig. 4 A) . In addition, immunopreciptation of PSD-95 from the lysates revealed that levels of palmitoylated PSD-95 were significantly greater in cultures treated with Bph-PP1-compared to 1NM-PP1-treated cultures (palmitoylated PSD-95 ratio relative to Bph-PP1 treatment, 0.37 Ϯ 0.11; p Ͻ 0.001; N ϭ 4) (Fig. 4 B) . Neuronal cultures were subsequently exposed to antagonists of the three pathways downstream of TrkB: mitogen-activated protein kinase (MAPK), phosphoinositide 3 kinase (PI3K), and phospholipase C␥ (PLC␥) (Huang and Reichardt, 2003) . The PLC blocker U73122 significantly reduced PSD-95 palmitoylation (palmitoylated PSD-95 ratio relative to control, 0.35 Ϯ 0.17; p Ͻ 0.001; N ϭ 4), while blockers of MAPK (PD98059; palmitoylated PSD-95 ratio relative to control, 1.15 Ϯ 0.21; p ϭ 0.38; N ϭ 4) and PI3K (wortmannin; palmitoylated PSD-95 ratio relative to control, 1.03 Ϯ 0.1; p ϭ 0.21; N ϭ 4) did not (Fig. 4C) . PLC␥ is known to regulate PKC. Consequently, we applied chelerythrine, a broad PKC blocker. This treatment also suppressed PSD-95 palmitoylation (palmitoylated PSD-95 ratio relative to control, 0.39 Ϯ 0.08; p Ͻ 0.001; N ϭ 4) (Fig. 4 D) . PKM is a brain-specific variant of PKC. It is an important mediator of late, protein synthesis-dependent LTP in hippocampus (Sajikumar et al., 2005; Pastalkova et al., 2006) and is critical for maintenance of long-term memory (Shema et al., 2007 (Shema et al., , 2011 . PKM also regulates experience-induced LTP in primary visual cortex (Cooke and Bear, 2010) , and BDNF activates PKM (Adasme et al., 2011) . Furthermore, blockade of PKM has recently been shown to reduce PSD-95 in Xenopus tadpole tectal neurons (Liu et al., 2009) . PKM can be specifically inhibited by a pseudosubstrate peptide that is myristoylated and thus permeable to cell membranes (Pastalkova et al., 2006) . Therefore, we treated another set of cultures with BDNF and the myristoylated PKM pseudosubstrate. These showed a significant reduction in PSD-95 palmitoylation (palmitoylated PSD-95 ratio relative to control, 0.48 Ϯ 0.18; p Ͻ 0.001; N ϭ 4) compared to cultures treated with BDNF and the scrambled peptide (palmitoylated PSD-95 ratio relative to control, 0.94 Ϯ 0.06; p ϭ 0.2; N ϭ 4) or BDNF alone (Fig. 4 E) . Future experiments using in vivo deletions of PLC␥ and PKM will be necessary to confirm this current, single-dose, in vitro pharmacological blockade.
PKM blockade causes reduction in PSD-95 puncta
We next examined the contribution of PKM to synaptic localization of PSD-95 in vivo. At P13, before EO, we injected either the PKM pseudosubstrate or the scrambled pseudosubstrate into the VC of animals expressing PSD-95-GFP in layer 2/3 neurons. We added Alexa-647-conjugated cholera toxin B (ACTB), a non-toxic and broad neuronal tracer, to the injected peptide solutions. Eyes were opened immediately after the peptide/ACTB injection, and 24 h later the animals were killed, and VC layer 2/3 neurons were examined for PSD-95 puncta distribution and intensity (Fig. 5 A, B) . VC neurons expressing ACTB and presumably PKM inhibitory pseudosubstrate showed significantly lower total pixel intensity (9200 Ϯ 1300) than neurons containing the scrambled peptides (28,400 Ϯ 4200; N ϭ 16 dendrites in 8 neurons for each group; p Ͻ 0.001).
We ensured that the pseudosubstrate was the active agent in the cells analyzed by building pseudosubstrate and scrambled peptide DNA constructs tagged with RFP (RFP-2A-pseudo and RFP-2A-scr, respectively) DNA (Fig. 6A) . First, we confirmed that endogenous PSD-95 puncta were reduced in cultured cortical neurons expressing the pseudosubstrate-RFP (N ϭ 22 dendrites in 9 cells; mean, 7.10 Ϯ 1.0 puncta per 100 m dendrite) compared to the scrambled-peptide-RFP (N ϭ 24 dendrites in 9 cells; mean, 10.2 Ϯ 0.9 puncta per 100 m of dendrite; peudosubstrate-RFP vs scrambled-peptide-RFP, p Ͻ 0.05) (Fig. 6 B) . To better discern the PSD-95 puncta changes, we next either co-electroporated the pseudosubstrate-RFP or the scrambled-peptide-RFP construct with PSD-95-GFP into separate cortices at E15.5 and examined PSD-95 puncta in VC layer 2/3 24 h after EO (Fig. 6C,D) . Neurons expressing the pseudosubstrate-RFP showed significantly lower total puncta intensity (33,900 Ϯ 3500) than neurons expressing the scrambledpeptide-RFP (24,500 Ϯ 2800; N ϭ 18 for each group; p Ͻ 0.01).
Finally, we asked whether any palmitoylation enzyme(s) were regulated by PKM. Protein palmitoylation is accomplished by the ZDHHC family of PATs. However, there are over 20 known PATs (Fukata and Fukata, 2010) . We selected six ZDHHCs based on known synaptic function and proven PSD-95 palmitoylation ability (Fukata et al., 2004; Huang et al., 2004; Fukata and Fukata, 2010) . We reasoned that the putative PAT(s) should be phosphorylated by PKM. We transfected HA-tagged ZDHHCs 2, 3, 7, 8, 15, and 17 (gifts from M. Fukata, National Institute for Physiological Sciences, Okazaki, Aichi, Japan) in sets of primary cortical neuronal cultures, and, for each PAT, cultures were treated with either scrambled peptide or pseudosubstrate. Subsequently, we pulled down the PATs from culture lysates using an anti-HA antibody and immunoblotted to visualize HA-tagged ZDHHCs (Fig. 7A) . As indicated by asterisks in Figure 7A , amounts of each PAT were equal between the two treatment groups (ZDHHC2 pseudo /ZDHHC2 scr ϭ 1.02 Ϯ 0.02; ZDHHC3 pseudo /ZDHHC3 scr ϭ 1.05 Ϯ 0.08; ZDHHC7 pseudo / ZDHHC7 scr ϭ 1.02 Ϯ 0.03; ZDHHC8 pseudo /ZDHHC8 scr ϭ 0.98 Ϯ 0.03; ZDHHC15 pseudo /ZDHHC15 scr ϭ 1.0 Ϯ 0.02; ZDHHC17 pseudo / ZDHHC17 scr ϭ 0.95 Ϯ 0.08). We then reprobed the blotting membranes with an antibody against phosphorylatedserine PKC family substrates and found that only ZDHHC8 showed a pronounced phosphorylation band in the scrambled pseudosubsrate-treated control cultures, whereas the phosphorylation band was absent when cultures were treated with the PKM pseudosubstrate (Fig. 7B) .
These findings motivated us to test whether overexpression of ZDHHC8 could rescue the in vivo suppression of PSD-95 synaptic redistribution by PKM blockade in layer 2/3 VC neurons after EO. We electroporated constructs for PSD-95-GFP, RFPtagged pseudosubstrate, and HA-tagged ZDHHC8 in utero and, 1 d after EO, killed the animals and stained the cortical slices with an anti-HA tag antibody followed by Alexa-647-conjugated secondary antibody. With this procedure, we determined whether a GFP-and RFP-containing neuron also overexpressed ZDHHC8 (Fig. 7C) . We found that the addition of the WT ZDHHC8 gene completely restored total pixel intensity of PSD-95-GFP puncta, despite the pseudosubstrate inhibition of PKM (Fig. 7 D, E) (33,000 Ϯ 3600; N ϭ 18; p Ͻ 0.01 between RFP-2A-pseudo and RFP-2A-pseudo ϩ ZDHHC8). In the same slice, some neurons expressed PSD-95-GFP and RFPtagged pseudosubstrate, but no detectable ZDHHC8. In these neurons, total pixel intensity of PSD-95-GFP puncta was suppressed, similar to neurons in Figure 6C (right).
Discussion
Transport of PSD-95 to synapses is dependent on pattern vision and mediated by activation of TrkB and PKM in mouse visual cortex Previously, we reported that redistribution of PSD-95 to synapses is triggered by EO and the onset of the patterned vision in young rats (Yoshii et al., 2003) . AM-PAR increases at synapses follow within the next 24 h (Lu and Constantine-Paton, 2004) . During this interval, more TrkB is associated with PSD-95 (Yoshii and Constantine-Paton, 2007) . The current study confirms that the same activitydependent transport occurs in mouse visual cortex and is dependent on the BDNF/TrkB signaling pathway. We show that EO induces increases of synaptosome PSD-95 levels, while PSD-95 levels in whole lysates remain stable between P12 and P14 (Fig. 2 A) . The punctate distribution of PSD-95 in control visual cortex also increases after EO (total pixel intensity, ϳ30,000) compared with that before EO (total pixel intensity, ϳ7000) in visual cortex (Fig. 3C,D) . In addition, TrkB phosphorylation gradually increases during development (Fig. 1G) , over a period encompassing EO. The increase in TrkB phosphorylation is consistent with an increase in BDNF mRNA during this period (Castren et al., 1992) .
Our data also indicate that specific TrkB blockade using a chemical genetic approach suppresses increases in PSD-95 synthesis in whole lysates during early development (Fig. 1 F, J ) and enrichment of PSD-95 at visual cortical synapses triggered by EO (Fig. 2 A) . Suppression of TrkB signaling also causes a reduction of endogenous PSD-95 puncta and increases endogenous PSD-95 immunolabeling in cell bodies, suggesting a decrease in PSD-95 transport to synapses (Fig. 2 B) . These results indicate that, in intact mouse visual cortex, TrkB signaling regulates the developmental increase in PSD-95 and that EO, the onset of pattern vision, facilitates TrkB activation as well as the synaptic redistribution of PSD-95.
Chemical genetic inactivation of TrkB signaling in the intact TrkB F616A mouse has been shown to block the reinstatement of deprived eye synapses after brief monocular deprivation (Kaneko et al., 2008) . In light of the present work, this is likely due to failure to deliver PSD-95 to the synapses driven by the newly reactivated eye's cortical inputs, because reduction or elimination of PSD-95 is known to decrease synapse number on young neurons (Beique et al., 2006; Elias et al., 2006; Constantine-Paton, 2007, 2010) , and we have shown previously that 4 d of eye reclosure after EO causes PSD-95 levels in visual neuron synaptic fractions to decrease to pre-EO levels with a rapid recovery after eye reopening (Yoshii et al., 2003) .
TrkB regulates excitatory synapse maturation and synaptic localization of PSD-95
The role of BDNF/TrkB signaling on inhibitory neurons in visual cortex has been well studied (Huang et al., 1999) . Evidence for BDNF/TrkB functions in pyramidal neurons (Bracken and Turrigiano, 2009 ) and their developing spines is also abundant (Tyler and Pozzo-Miller, 2003; Chakravarthy et al., 2006; Tanaka et al., 2008) . Furthermore, it has been established that PSD-95 at synapses is crucial to spine maturation (Kim and Sheng, 2004; van Zundert et al., 2004) and that BDNF/TrkB signaling plays a central role in facilitating glutamate synapse stabilization/ maturation through the PSD-95 scaffold (Ji et al., 2005; Constantine-Paton, 2007, 2010) . Our current results provide further evidence that BDNF/TrkB signaling regulates transport of PSD-95 to synapses in layer 2/3 pyramidal neurons, thus contributing to activity-dependent maturation of excitatory visual synapses.
PSD-95 palmitoylation is regulated by a trophic factor signaling pathway Palmitoylation has been shown to be required for PSD-95 transport and synaptic insertion (Topinka and Bredt, 1998; ElHusseini et al., 2000b) , and PSD-95 palmitoylation is known to require synaptic activity (El-Husseini Ael et al., 2002; Noritake et al., 2009) . Considerably less is known about the signaling pathway that regulates this palmitoylation. Here, we document that the TrkB pathway regulates palmitoylation of PSD-95 through PLC and the PKC/PKM pathway (Fig. 4 -7) . We also show, for the first time, that PKM regulates phosphorylation of only ZDHHC8 out of the six palmitoyl acyltransferases known to act on PSD-95 ( Fig. 7 A, B) , and overexpression of ZDHHC8 rescues significant amounts of PSD-95 transport to synapses in the presence of the PKM pseudosubstrate, which reduces, but probably does not completely block, PKM activity when electroporated in vivo ( Fig. 7C-E) . One possibility is that phosphorylation of ZDHHC8 directly regulates its enzymatic function of palmitoylation through a mechanism such as conformational change. However, phosphorylation may also regulate intracellular localization or stability of ZDHHC8.
Several reports indicate that one mechanism through which PKM might work to maintain LTP and memory is to block the endocytosis of the AMPAR subunit GluR2 by interfering with N-ethylmaleimide-sensitive factor-mediated GluR2 endocytosis (Yao et al., 2008; Migues et al., 2010) . GluR2 is also palmitoylated by GODZ (Golgi apparatus-specific protein with a DHHC zinc finger domain; or ZDHHC3) (Hayashi et al., 2005) . However, palmitoylation of GluR2 was unchanged between control and TrkB-blocked samples (data not shown), indicating differential regulations of these two palmitoylated synaptic proteins.
Palmitoylation and vesicular transport: two critical components of PSD-95 trafficking
Neurotrophins and protein palmitoylation interact in key ways with diverse membrane-associated proteins and regulate their subcellular localizations and functions throughout the brain. ZDHHC8 has been shown to be localized in the Golgi apparatus and to palmitoylate PSD-95 (Mukai et al., 2008) .
We previously used fluorescent recovery after photobleaching and in vitro immunocytochemistry to show that the PI3K-Akt pathway is required for the NMDAR driven, BDNF-induced trafficking of PSD-95 from visual cortical neuron somata to dendrites. The same report showed that TrkB signaling facilitates PSD-95 transport from the ER to the Golgi apparatus (Yoshii and Constantine-Paton, 2007) . Our current work shows that EO-induced increase in visual activity, also operating through BDNF/TrkB signaling, upregulates PLC␥ signaling to induce ZDHHC8-dependent palmitoylation of PSD-95. Thus BDNF/TrkB signaling drives two synergistic pathways in parallel: (1) the PI3K-Akt pathway triggers PSD-95 vesicular transport systems in cell bodies and dendrites to bring the scaffold to the synapse; (2) the PLC pathway drives palmitoylation of PSD-95, allowing the scaffold synthesized in cytoplasm to attach to (N ϭ 3) . The red rectangle encloses the Igs. The asterisk indicates phospho-ZDHHC8. C, Visual cortical neurons electroporated at E15.5 with constructs coding for pseudosubstrate-RFP, HA-tagged ZDHHC8, and PSD-95-GFP. Insets depict coexpression of pseudosubstrate-RFP (red) and HAtagged ZDHHC8 stained with anti-HA tag antibody (pseudocolored in white for better visibility). The diagram illustrates the sequence of the in vivo experiments. D, E, An overexpression of ZDHHC8 rescues suppression of PSD-95 puncta intensity by the PKM inhibitory pseudosubstrate. Two branches from nine neurons (N ϭ 18 total) were analyzed for each group. **p Ͻ 0.01. Error bars represent SEM. Scale bars: 10 m. plasma membranes and travel via the dendritic microtubule transport system as we have shown previously (Yoshii and ConstantinePaton, 2007) . TrkB-induced increases in PSD-95 at synapses (Yoshii et al., 2003; Ji et al., 2005; Yoshii and Constantine-Paton, 2007 ) and the subsequent synaptic signaling mediated through this scaffold (Ehrlich et al., 2007; Yoshii and Constantine-Paton, 2007 ) are known to increase stabilization of young synapses, a precondition for many of the events involved in neural circuit maturation (McAllister et al., 1999; Poo, 2001; Huang and Reichardt, 2003; Minichiello, 2009; Yoshii and Constantine-Paton, 2010) .
Synaptic trafficking of PSD-95 is regulated by both TrkB signaling and PKM PLC␥-binding sites on TrkB have been shown to be crucial for maintaining late LTP (Minichiello et al., 2002) and also limbic epileptogenesis (He et al., 2010) . It is widely accepted that PLC␥ activates PKC and that PKM is a brain-specific PKC variant. In fact, BDNF has been shown to upregulate the expression and, because PKM is a constitutively active enzyme, the activity of PKM (Adasme et al., 2011) . Furthermore, both TrkB and PKM are crucial for the maintenance of late-phase LTP, consolidation of long-term memory (Pastalkova et al., 2006; Minichiello, 2009) , synaptic tagging (Barco et al., 2005; Sajikumar et al., 2005) , and synaptic localization of PSD-95 (Yoshii and Constantine-Paton, 2007; Liu et al., 2009 ).
Conclusion
We have documented a new mechanism for trafficking synaptic molecules in vivo that is triggered by the developmental milestone of eye opening; namely, TrkB and PKM play significant, if not critical roles in the transport of PSD-95 to synapses after eye opening in layer 2/3 pyramidal neurons of mouse visual cortex. This mechanism involves the PSD-95 palmitoylation enzyme ZDHHC8, which is thus a prime candidate for effecting the critical palmitoylation known to bring PSD-95 to synapses. The same or a similar mechanism is likely to play a role in various forms of learning and memory as well as the developmental tuning of circuitry as a result of environmentally induced activity.
Perhaps most significantly, the knowledge of a neurotrophinpathway-dependent palmitoylation of PSD-95 can provide insights and eventual treatments for devastating developmental and psychiatric diseases such as autism spectrum disorders and schizophrenia, to name a few (Mukai et al., 2008; Fukata and Fukata, 2010; Yoshii and Constantine-Paton, 2010) . This TrkBtriggered pathway is also involved in learning and memory, and also may be critical to the maintenance of memory and cognition in the aging brain (Shema et al., 2011) .
